1971
DOI: 10.1001/archpedi.1971.02100160050003
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Combined Live Measles, Mumps, Rubella Vaccine

Search citation statements

Order By: Relevance

Paper Sections

Select...
23
1
0
0

Citation Types

1
4
0
0

Year Published

1971
1971
2024
2024

Publication Types

Select...
13
11

Relationship

0
24

Authors

Journals

citations

Cited by 24 publications

(5 citation statements)
references

References 2 publications

1
4
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…Of 163 reported cases in the United States in 1972,44.2% of the patients were age 5--9, 16.6% age 0-4, and 16.0% age 10--14. The remainder of cases were scattered throughout all other age groups. A similar age distribution was seen in 76 cases of aseptic meningitis reported in the same period. Mumps-associated deaths in 158 cases from 1966 to 1971 were distributed by age as follows: 38% over age 40,22.2% age 5--9 yr, and 19% age 0-4 yr.…”
Section: Age
supporting
confidence: 81%
How this paper cites the one you are viewing
“…Of 163 reported cases in the United States in 1972,44.2% of the patients were age 5--9, 16.6% age 0-4, and 16.0% age 10--14. The remainder of cases were scattered throughout all other age groups. A similar age distribution was seen in 76 cases of aseptic meningitis reported in the same period. Mumps-associated deaths in 158 cases from 1966 to 1971 were distributed by age as follows: 38% over age 40,22.2% age 5--9 yr, and 19% age 0-4 yr.…”
Section: Age
supporting
confidence: 81%
How this paper cites the one you are viewing
“…These candidate LAMVs produced no disease in macaques and provided protection from challenge with wild-type measles virus (70,71). The LAMV licensed in 1963 frequently produced fever and rash (72,73). Further passage in tissue culture yielded the current LAMVs that cause fever and rash in less than 10% of immunized children (74,75).…”
Section: Measles Vaccines
mentioning
confidence: 99%
How this paper cites the one you are viewing
“…MV is an antigenically invariant pathogen where acute infection elicits protective immunity in convalescent persons. This allowed the licensing of a live virus attenuated vaccine via passage of a human isolate through tissue culture [97]. Vaccination provides life-long immunity after two inoculations during childhood.…”
Section: Measles
mentioning
confidence: 99%